Anthony Curro is an accomplished executive in the biotechnology and medical device industries, currently serving as Chair of the Board at Xylyx Bio and an executive board member at Immplacate, Inc. With over 35 years of experience, Curro has held significant roles including CEO of Spruce Technology and vice president at both AllianceBernstein and Compumedics. They lead the NIH RADx COVID-19 Response Program, a $500 million initiative aimed at advancing COVID-19 testing technologies. Curro holds an MBA from Columbia Business School and a BA, magna cum laude, from Fairleigh Dickinson University, and has served in various alumni and nonprofit leadership roles.
Location
New York, United States
This person is not in the org chart
This person is not in any offices